Search

everythinglearnresearchcommunity

for

Search:↓

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Spironolactone helps regrow hair in women with hair loss.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Minoxidil effectively treats female pattern hair loss.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride shows promise for female hair loss, but more research needed.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.